You are here:Home-Chemical Inhibitors & Agonists-GPCR-TGR5 (GPCR19, GPR131, GPBAR1)-ZY12201
ZY12201

Chemical Structure : ZY12201

CAS No.: 1430210-54-0

ZY12201 (ZY 12201, TGR5 agonist 6g)

Catalog No.: PC-72133Not For Human Use, Lab Use Only.

ZY12201 (TGR5 agonist 6g) is a highly potent, selective and orally efficacious TGR5 agonist with EC50 of 57 pM and 62 pM for hTGR5 and mTGR5, respectively.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    ZY12201 (TGR5 agonist 6g) is a highly potent, selective and orally efficacious TGR5 agonist with EC50 of 57 pM and 62 pM for hTGR5 and mTGR5, respectively.
    TGR5 agonist 6g showed dose-dependent activation of a cAMP responsive element-driven luciferase reporter in TGR5 overexpressing CHO K1 cells (EC50=14 nM).
    TGR5 agonist 6g modulated GLP-1 secretion in vitro at 10 and 30 μM concentration in NCI-H716 cells.
    TGR5 agonist 6g exhibited good selectivity against FXR (EC50=6.4 uM).
    TGR5 agonist 6g showed a dose-dependent inhibition of TNF-α in an LPS-induced cytokine release assay in human whole blood, similar to prednisolone (IC50=251 nM).
    TGR5 agonist 6g (30 mg/kg, p.o.) increased plasma GLP-1 levels by 3.8-fold with respect to vehicle control in C57 mice, robustly lowered the blood glucose excursion in a dose-proportional manner with ED50 of 7.9 mg/kg and ED90 of 29.2 mg/kg.

    Physicochemical Properties

    M.Wt 558.672
    Formula C31H31FN4O3S
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    2-((2-(4-(1H-imidazol-1-yl)phenoxy)ethyl) thio)-5-(2-(3,4-dimethoxyphenyl) propan-2-yl)-1-(4-fluoro phenyl)-1H-imidazole

    References

    1. Sojitra C, et al. SN Appl Sci. 2021;3(6):660.

    3. Joshi VM, et al. Org Process Res Dev. 2020;8:1508–1514.

    4. Agarwal S, et al. ACS Med Chem Lett. 2016;7(1):51–55.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: